Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
Read more...NEW YORK (Reuters Health) - Rotating shift work can wreak havoc with bodily functions such as sleep and bowel movements. Now study findings hint that rotating work schedules may also increase risk for irritable bowel syndrome.
Read more...Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
Read more...Sucampo Pharmaceuticals Inc. surged 42 percent over two days after reporting that its experimental medicine for opioid-induced bowel dysfunction met goals in a late-stage clinical trial.
Read more...After a successful phase 3 clinical trial, Sucampo Pharmaceuticals of Bethesda is ready to apply for U.S. regulatory approval to market its constipation drug to people who have bowel dysfunction from taking morphine and codeine for chronic, non-cancer pain.
Read more...
Candida detox
Instructions to mix miracle mineral
Use miracle mineral for lyme disease
Texas mms supplier
Usa mms supplier
Only 2 to 3 weeks to live
Canada mms supplier
Holistic healing protocol
Lyme crohns disease and mms
Buy mms miracle mineral
Swine flu epidemic
Improve mms taste
Toxin release
Avian flu and mms
Hemorrhagic fever
Chrohns disease and mms
Pandemic alert
Chlorine dioxide